Does TOLODODEKIN ALFA Cause Therapy partial responder? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Therapy partial responder have been filed in association with TOLODODEKIN ALFA. This represents 2.7% of all adverse event reports for TOLODODEKIN ALFA.
15
Reports of Therapy partial responder with TOLODODEKIN ALFA
2.7%
of all TOLODODEKIN ALFA reports
3
Deaths
2
Hospitalizations
How Dangerous Is Therapy partial responder From TOLODODEKIN ALFA?
Of the 15 reports, 3 (20.0%) resulted in death, 2 (13.3%) required hospitalization, and 5 (33.3%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOLODODEKIN ALFA. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TOLODODEKIN ALFA Cause?
Off label use (81)
Neutropenia (59)
Plasma cell myeloma (52)
Thrombocytopenia (48)
Anaemia (44)
Drug ineffective (44)
Infusion related reaction (42)
Pneumonia (37)
Pyrexia (34)
Febrile neutropenia (31)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which TOLODODEKIN ALFA Alternatives Have Lower Therapy partial responder Risk?
TOLODODEKIN ALFA vs TOLTERODINE
TOLODODEKIN ALFA vs TOLVAPTAN
TOLODODEKIN ALFA vs TOPAMAX
TOLODODEKIN ALFA vs TOPIRAMATE
TOLODODEKIN ALFA vs TOPOTECAN